Access to anti-retroviral drugs, female (%) in Estonia
Estonia: Access to anti-retroviral drugs, female (%) was 70.0% in 2022. ◆ Volatile
Access to anti-retroviral drugs, female in Estonia, 2000–2022
Source: UNAIDS estimates. Measured in %.
Analysis
The most recent figure for access to anti-retroviral drugs, female in Estonia is 70.0%, measured in 2022.
The figure is down 2.8% on the previous year and up 48.9% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Estonia peaked at 76.0% in 2019 and was at its lowest, 2.0%, in 2002.
That places Estonia 82nd out of 141 countries with data for 2022, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female (%) in Estonia, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 14.0% | — |
| 2001 | 3.0% | -78.6% |
| 2002 | 2.0% | -33.3% |
| 2003 | 2.0% | +0.0% |
| 2004 | 3.0% | +50.0% |
| 2005 | 7.0% | +133.3% |
| 2006 | 11.0% | +57.1% |
| 2007 | 16.0% | +45.5% |
| 2008 | 22.0% | +37.5% |
| 2009 | 27.0% | +22.7% |
| 2010 | 35.0% | +29.6% |
| 2011 | 41.0% | +17.1% |
| 2012 | 47.0% | +14.6% |
| 2013 | 50.0% | +6.4% |
| 2014 | 54.0% | +8.0% |
| 2015 | 62.0% | +14.8% |
| 2016 | 68.0% | +9.7% |
| 2017 | 71.0% | +4.4% |
| 2018 | 74.0% | +4.2% |
| 2019 | 76.0% | +2.7% |
| 2020 | 73.0% | -3.9% |
| 2021 | 72.0% | -1.4% |
| 2022 | 70.0% | -2.8% |
Estonia compared with similar countries
- Estonia's 70.0% is below the median for high income countries, which is 82.0%, 85% of the median. (39 countries reporting)
- Estonia's 70.0% is below the median for Europe & Central Asia, which is 83.0%, 84% of the median. (33 countries reporting)
Biggest year-on-year movements
Years where Access to anti-retroviral drugs, female (%) in Estonia changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2005 | +133.3% | 3.0% | 7.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 10.7% | 2.0% | 27.0% | 10 |
| 2010s | 57.8% | 35.0% | 76.0% | 10 |
| 2020s | 71.7% | 70.0% | 73.0% | 3 |
Countries ranked near Estonia
More gender data for Estonia
- Child population (UN estimates and projections) 178.81 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -2.67 % change on previous year (2030)
- Population 1,124 (2030)
- Working-age population (UN estimates and projections) 1,124 (2030)
- Population (UN estimates and projections), annual growth rate -0.1883 % change on previous year (2030)
- Age population, age 00, female, interpolated 5,081 (2025)
- Age population, age 00, male, interpolated 5,410 (2025)
- Age population, age 01, female, interpolated 5,159 (2025)
- Age population, age 01, male, interpolated 5,497 (2025)
- Age population, age 02, female, interpolated 5,416 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Estonia?
- Access to anti-retroviral drugs, female in Estonia was 70.0% in 2022, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Estonia?
- The highest recorded value was 76.0% in 2019.
- What is the lowest access to anti-retroviral drugs, female recorded in Estonia?
- The lowest recorded value was 2.0% in 2002.
- How does Estonia rank for access to anti-retroviral drugs, female?
- Estonia ranks 82nd out of 141 countries with data for 2022.
- Is access to anti-retroviral drugs, female rising or falling in Estonia?
- Over the last ten years it is up 48.9%. The long-run trend across the full record is volatile.
- Where does this Estonia data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 23 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.